Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jinhai International Group Holdings Limited ( (HK:2225) ) just unveiled an announcement.
Jinhai Medical Technology Limited has announced that non-executive director and vice-chairman of the board, Mr. Jiang Jiangyu, has resigned with effect from 29 January 2026 due to other business commitments requiring more of his time. The company stated that Mr. Jiang has no claims against the firm, no disagreements with the board, and no other matters needing shareholders’ attention in relation to his departure, suggesting an orderly transition. Following his resignation, the board now consists of three executive directors, one non-executive director and three independent non-executive directors, indicating that overall board composition and corporate governance remain intact despite the leadership change.
The most recent analyst rating on (HK:2225) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Jinhai International Group Holdings Limited stock, see the HK:2225 Stock Forecast page.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited is a Cayman Islands-incorporated medical technology company listed on the Hong Kong Stock Exchange under stock code 2225. The company is governed by a seven-member board comprising executive, non-executive and independent non-executive directors, reflecting a standard listed-company governance structure in Hong Kong’s healthcare and medical technology sector.
Average Trading Volume: 8,877,408
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.95B
Learn more about 2225 stock on TipRanks’ Stock Analysis page.